Brief: Design Therapeutics Reports Pipeline And Business Progress And Fourth Quarter And Full Year 2021 Financial Results
10/03/2022 21:04
March 10 (Reuters) - Design Therapeutics Inc DSGN.O :
* DESIGN THERAPEUTICS REPORTS PIPELINE AND BUSINESS PROGRESS
AND
FOURTH QUARTER AND FULL YEAR 2021 FINANCIAL RESULTS
* DESIGN THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.20
Source text for Eikon: ID:nGNX2FFNx4
Further company coverage: DSGN.O
Recent news on Design Therapeutics
See all newsDesign Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Design Therapeutics Q2 net loss narrower than expected
Brief: Design Therapeutics Q2 Basic EPS USD -0.32
Design Therapeutics Inc expected to post a loss of 34 cents a share - Earnings Preview
Brief: Design Therapeutics Announces Initiation Of Patient Dosing In Phase 1 Multiple Ascending Dose Trial Of Dt-818 For Myotonic Dystrophy Type-1